ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,199.50
0.00%
US Tech 100
17,596.80
1.18%
Dow Jones
38,763.45
0.00%
Brent Oil
78.145
-0.30%
Bitcoin
58,034.80
5.46%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSXV

  6. Penfold Capital Acquisition II Corp. (PAC.P) Quote

Penfold Capital Acquisition II Corp.

Penfold Capital Acquisition II Corp. (PAC.P)

TSXV
0.00
0.00
(0.00%)
Closed August 08 4:00PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

PAC.P Latest News

More News

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO Reports Inducement Grant Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., Aug. 1, 2024 PLYMOUTH MEETING, Pa., Aug. 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology...

August 01 2024
PR Newswire (US)

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107 PR Newswire PLYMOUTH MEETING, Pa., July...

July 25 2024
PR Newswire (US)

INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024

INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLYMOUTH MEETING, Pa., July 25, 2024 PLYMOUTH MEETING, Pa., July 25, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO...

July 25 2024
PR Newswire (US)

INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway

INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway PR Newswire PLYMOUTH MEETING, Pa., July 11, 2024 Award recognizes the...

July 11 2024
PR Newswire (US)

INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer

INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer PR Newswire PLYMOUTH MEETING, Pa., July 2, 2024 Mr. Egge brings over 25 years of biopharmaceutical experience building...

July 02 2024
PR Newswire (US)

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO Reports Inducement Grant Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., July 1, 2024 PLYMOUTH MEETING, Pa., July 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology...

July 01 2024
PR Newswire (US)

INOVIO Added to Russell 2000® Index Effective July 1, 2024

INOVIO Added to Russell 2000® Index Effective July 1, 2024 PR Newswire PLYMOUTH MEETING, Pa., July 1, 2024 PLYMOUTH MEETING, Pa., July 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a...

July 01 2024
PR Newswire (US)

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc. PR Newswire PLYMOUTH MEETING, Pa., June 4, 2024 PLYMOUTH MEETING, Pa., June 4, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a...

June 04 2024
PR Newswire (US)

INOVIO Reports Inducement Grants Under Inducement Plan

INOVIO Reports Inducement Grants Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., May 31, 2024 PLYMOUTH MEETING, Pa., May 31, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology...

May 31 2024
PR Newswire (US)

Form 8-K - Current report

May 28 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.05
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.43
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.05
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.43
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.05
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.43
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0

Discussion

View Full Feed
PonkenPlonken PonkenPlonken 2 minutes ago
PFE in zing fingers --- DESPERATE for an agent
Imagine a bar late at night ..... people go home with whomever is left.
PFE
jedijazz jedijazz 2 minutes ago
$ABVE 5-Day Percent Change +9.02% Average Volume 191,360 #BULLISH #Newly Listed #NYSE #TechnicalAnalysis https://www.barchart.com/stocks/quotes/ABVE/technical-analysis
ABVE
urge2surge urge2surge 2 minutes ago
Great momo chart.
https://stockcharts.com/sc3/ui/?s=IDVV
IDVV
jbsliverer jbsliverer 2 minutes ago
Elon Musk shares fake news claiming UK rioters will be sent to ‘detainment camps’


https://x.com/POLITICOEurope/status/1821507625470595074

POLITICOEurope
@POLITICOEurope
Elon Musk is at it again.

Amid an ongoing feud with the British
CET
Awl416 Awl416 2 minutes ago
GSE Solutions to be Acquired by Pelican Energy Partners
GVP
Foogie88 Foogie88 2 minutes ago
I know what an idiot he is!
NWBO
RIGATONI RIGATONI 2 minutes ago
$2.40 turn up the volume, let's get some news of substance ~Rig
MoneyMan MoneyMan 2 minutes ago
Listening now....... Shelby said Agros high year of 2022 they did $22 million in revenue!

$SINC
SINC
buysellrepeat buysellrepeat 2 minutes ago
Yes. It’s hard to separate money and emotion sometimes. Especially in scenarios like this. Anyone that’s able to can see that like you said, there are lots of pieces moving.
TXTM
PonkenPlonken PonkenPlonken 2 minutes ago
so so overbought
people got married to this stock and cant let it go
SGMO
dshade dshade 2 minutes ago
anyone else show the name change in their accounts?
ECSL
$b_rich$ $b_rich$ 2 minutes ago
Good morning PBS!
DiscoverGold DiscoverGold 3 minutes ago
$NVDA Hold the Demand Zone Line
By: TrendSpider | August 8, 2024

• $NVDA HOLD THE LINE.

pbs.twimg.com/media/GUdbCE_aYAA-nDa?format=jpg&name=medium

https://x.com/TrendSpider/status/1821524678177136952 Read Full Story »»»

NVDA
$b_rich$ $b_rich$ 3 minutes ago
HRAL news:

https://www.otcmarkets.com/stock/HRAL/news/Hear-AtLast-and-ACT-Investment-Group-Sign-Agreement-for-Purchase-of-Income-Properties-In-North-America?id=449420
HRAL
newman2021 newman2021 3 minutes ago
https://www.marketwatch.com/story/merck-says-its-discontinuing-a-late-stage-trial-of-a-lung-cancer-treatment-after-high-number-of-adverse-events-98c50297?mod=mw_latestnews

Hahaha Keytruda falling to dust. Our combo with the CIs is going to rule the oncology space for sure soon! Chee
NWBO
Duma Duma 3 minutes ago
Looks like all of us bought, I did also.
webbie01 webbie01 3 minutes ago
PGEN under $1
PGEN
LOVELWLG LOVELWLG 3 minutes ago
Not this or that just something 🤣🤣🤣🤣
LWLG
jimr1717 jimr1717 3 minutes ago
Sounds like bagasse is like eating cardboard.

Maybe SGP++ cardboard will be studied next.
IFUS
TrendTrade2016 TrendTrade2016 3 minutes ago
in for a magnet at 59c
CDT
SeniorApollo SeniorApollo 4 minutes ago
At a minimum, it should bring some clarity on the biggest elephants in the room.
Was the Q1 revenue real or not?
Who is currently running the company?
NSAV
biosectinvestor biosectinvestor 4 minutes ago
Thanks Vator! I can’t wait to hear what they report.
NWBO
vinsterr vinsterr 4 minutes ago
I heard Q2 will show 24 Million dollars in revenues compared to 0$ in Q1
SPZI
exwannabe exwannabe 4 minutes ago
Riddle me this Ex. What’s a recently FDA approved drug (very recent) for Brain cancer that used a cross-over design? Ans: Vorasidenib
Yes, they ran a randomized trial with post progression crossover and the trial's predefined primary endpoint of PFS was a success. So the drug was approved. T
NWBO
$b_rich$ $b_rich$ 4 minutes ago
SWRM news:
https://www.otcmarkets.com/stock/SWRM/news/story?e&id=2943119
SWRM

Your Recent History

TSXV
PAC.P
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved